Medical Market Report

Global Human Growth Hormone Drugs Market By Type (Norditropin, Genotropin, Humatrope, Saizen, Omnitrope - the Somatropin Biosimilar, and Somatropin Biopartners), By Application (Prader-Willi Syndrome, Turner Syndrome, Short Stature Homeobox Gene, Small for Gestational Age, Chronic Renal Insufficiency, Short Bowel Syndrome, and Short Bowel Syndrome), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 136588
  • 18-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    The report on Human Growth Hormone Drugs Market offers in-depth analysis of market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report includes the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global human growth hormone drugs market is segmented on the basis of Type, Application, and geography.

    The Worldwide market for Human Growth Hormone Drugs Market is expected to grow at a CAGR of roughly x.x% over the next nine years, and will reach US$ XX.X Mn in 2028, from US$ XX.X Mn in 2018, according to a new Market.us (Prudour Research) study.

    Human Growth Hormone Drugs Market Scope:

    By type, the market is segmented into Norditropin, Genotropin, Humatrope, Saizen, Omnitrope – the Somatropin Biosimilar, and Somatropin Biopartners. By Application, the market is divided into Prader-Willi Syndrome, Turner Syndrome, Short Stature Homeobox Gene, Small for Gestational Age, Chronic Renal Insufficiency, Short Bowel Syndrome, and Short Bowel Syndrome.
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Eli Lilly and Company (US), Ferring Holding SA (Switzerland), Genentech Inc. (US), GeneScience Pharmaceuticals Co. Ltd. (China), Merck KgaA (Germany), Novo Nordisk A/S (Denmark), Novo Nordisk A/S (Denmark), and Sandoz International GmbH (Germany).

    Key Market Segments

    Type

    Norditropin
    Genotropin
    Humatrope
    Saizen
    Omnitrope – the Somatropin Biosimilar
    Somatropin Biopartners

    Application

    Prader-Willi Syndrome
    Turner Syndrome
    Short Stature Homeobox Gene
    Small for Gestational Age
    Chronic Renal Insufficiency
    Short Bowel Syndrome
    Short Bowel Syndrome

    Key Market Players included in the report:

    Eli Lilly and Company (US)
    Ferring Holding SA (Switzerland)
    Genentech Inc. (US)
    GeneScience Pharmaceuticals Co. Ltd. (China)
    Merck KgaA (Germany)
    Novo Nordisk A/S (Denmark)
    Novo Nordisk A/S (Denmark)
    Sandoz International GmbH (Germany)

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Human Growth Hormone Drugs Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Human Growth Hormone Drugs Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Human Growth Hormone Drugs Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Human Growth Hormone Drugs Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Human Growth Hormone Drugs Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Human Growth Hormone Drugs Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Human Growth Hormone Drugs sub-markets, depending on key regions (various vital states).
    To analyze Human Growth Hormone Drugs Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Human Growth Hormone Drugs Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2014 to 2019, and also prediction to 2028.
    Primary worldwide Human Growth Hormone Drugs Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Human Growth Hormone Drugs Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players3. Global Human Growth Hormone Drugs Market Overview
    

    3.1. Human Growth Hormone Drugs Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges  3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Production Analysis by Region/Company
    
  3.9. Industry chain Analysis
    
  3.10. Marketing Strategy4. Global Human Growth Hormone Drugs Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global Human Growth Hormone Drugs Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Norditropin
    

      4.4. Genotropin
    

      4.5. Humatrope
    

      4.6. Saizen
    

      4.7. Omnitrope – the Somatropin Biosimilar
    

      4.8. Somatropin Biopartners5. Global Human Growth Hormone Drugs Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global Human Growth Hormone Drugs Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Prader-Willi Syndrome
    

      5.4. Turner Syndrome
    

      5.5. Short Stature Homeobox Gene
    

      5.6. Small for Gestational Age
    

      5.7. Chronic Renal Insufficiency
    

      5.8. Short Bowel Syndrome
    

      5.9. Short Bowel Syndrome6. Global Human Growth Hormone Drugs Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Human Growth Hormone Drugs Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Human Growth Hormone Drugs Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Spain
    
     6.2.1.7. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Human Growth Hormone Drugs Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia-Pacific
    

      6.4. Latin America
    

        6.4.1. Latin America Human Growth Hormone Drugs Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Human Growth Hormone Drugs Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    
7. Global Human Growth Hormone Drugs Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. Eli Lilly and Company (US)
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments  7.4. Ferring Holding SA (Switzerland)
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments  7.5. Genentech Inc. (US)
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments  7.6. GeneScience Pharmaceuticals Co. Ltd. (China)
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments  7.7. Merck KgaA (Germany)
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments  7.8. Novo Nordisk A/S (Denmark)
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments  7.9. Novo Nordisk A/S (Denmark)
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments  7.10. Sandoz International GmbH (Germany)
    

        7.10.1. Company Overview
    
    7.10.2. Financial Highlights
    
    7.10.3. Product Portfolio
    
    7.10.4. SWOT Analysis
    
    7.10.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.